Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs.

In today’s competitive environment, many young people dream of becoming self-reliant, but the fear of heavy investment often holds them back. To address this challenge, government-backed initiatives ...